Targeting prolyl-tRNA synthetase to accelerate drug discovery against malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis, and coccidiosis.

Developing anti-parasitic lead compounds that act on key vulnerabilities are necessary for new anti-infectives. Malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis and coccidiosis together kill >500,000 humans annually. Their causative parasites Plasmodium, Leishmania, Toxoplasma, Crypto...

全面介紹

書目詳細資料
Main Authors: Jain, V, Yogavel, M, Kikuchi, H, Oshima, Y, Hariguchi, N, Matsumoto, M, Goel, P, Touquet, B, Jumani, R, Tacchini-Cottier, F, Harlos, K, Huston, C, Hakimi, M, Sharma, A
格式: Journal article
語言:English
出版: Elsevier 2017